1. Home
  2. MXCT vs FCT Comparison

MXCT vs FCT Comparison

Compare MXCT & FCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • FCT
  • Stock Information
  • Founded
  • MXCT 1999
  • FCT 2004
  • Country
  • MXCT United States
  • FCT United States
  • Employees
  • MXCT N/A
  • FCT N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • FCT Finance Companies
  • Sector
  • MXCT Health Care
  • FCT Finance
  • Exchange
  • MXCT Nasdaq
  • FCT Nasdaq
  • Market Cap
  • MXCT 242.4M
  • FCT 265.0M
  • IPO Year
  • MXCT 2021
  • FCT N/A
  • Fundamental
  • Price
  • MXCT $1.40
  • FCT $10.20
  • Analyst Decision
  • MXCT Buy
  • FCT
  • Analyst Count
  • MXCT 4
  • FCT 0
  • Target Price
  • MXCT $7.50
  • FCT N/A
  • AVG Volume (30 Days)
  • MXCT 1.2M
  • FCT 106.8K
  • Earning Date
  • MXCT 08-06-2025
  • FCT 01-01-0001
  • Dividend Yield
  • MXCT N/A
  • FCT 11.29%
  • EPS Growth
  • MXCT N/A
  • FCT N/A
  • EPS
  • MXCT N/A
  • FCT N/A
  • Revenue
  • MXCT $35,754,000.00
  • FCT N/A
  • Revenue This Year
  • MXCT N/A
  • FCT N/A
  • Revenue Next Year
  • MXCT $14.79
  • FCT N/A
  • P/E Ratio
  • MXCT N/A
  • FCT N/A
  • Revenue Growth
  • MXCT N/A
  • FCT N/A
  • 52 Week Low
  • MXCT $1.26
  • FCT $9.45
  • 52 Week High
  • MXCT $5.20
  • FCT $10.42
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 31.00
  • FCT 65.02
  • Support Level
  • MXCT $1.37
  • FCT $10.14
  • Resistance Level
  • MXCT $1.48
  • FCT $10.09
  • Average True Range (ATR)
  • MXCT 0.09
  • FCT 0.06
  • MACD
  • MXCT 0.02
  • FCT 0.02
  • Stochastic Oscillator
  • MXCT 46.43
  • FCT 95.83

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About FCT First Trust Senior Floating Rate Income Fund II of Beneficial Interest

First Trust Senior Floating Rate Income Fund II is a United States-based diversified, closed-end management investment company. Its investment objective is to seek a high level of current income. As a secondary objective, it attempts to preserve capital. The fund invests in a portfolio of senior secured floating-rate corporate loans (Senior Loans) of companies from different industries, such as Insurance, Software, Health Care Providers and Services, Professional Services, Health Care Technology, IT Services, and others.

Share on Social Networks: